Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Interview of the week

Interview: Dr Juan Abarca Cidon, president, HM Hospitales

We talk to Dr Abarca Cidon, part of the controlling family and current president of Spain's third-largest for-profit hospital group HM Hospitales with nearly €500m in sales. He talks strategy, Covid, and rumours of selling a stake in the company.

McDermott Will & Emery talks Europe’s complex regulatory landscape

Encroaching protectionism from governments across Europe is leading to some initiatives that might limit foreign investment in key strategic services like healthcare. Sharon Lamb, a partner with law firm MWE, talks to HBI about those new laws and a host of others introduced over the last year. It’s a complex regulatory and reimbursement landscape but MWE has a new report to help. 

Interview: Dr Peter Byloos, Optegra

As HBI reported last week, UK, Czechia and Poland-based ophthalmology platform Optegra Eye Health Care is being acquired by H2 Equity Partners. HBI caught up with Optegra CEO Dr Peter Byloos to hear his views on the market (and inevitably these days, the impact of COVID), and to find out about Optegra’s plans under new ownership. 

Interview: John Gladstone, Head of Healthcare Investment, International Capital Markets, EMEA, JLL

Health care looks like the promised land to property investors hit hard by the collapse of retail and office and deal flow is picking up, says John Gladstone at global real estate advisors.

Interview: Javier Román, CEO, Clece

Clece is one of Spain's largest homecare providers and is also present in the UK, with total domiciliary care sales of over €400m in 2019. HBI gets a snapshot of the business and its views on sector challenges from CEO Javier Román.

Interview: Massimiliano Colella, CEO, Evercare Group

We talk to the CEO of Evercare Group, the diverse conglomerate of South Asia and African hospitals that make up the $1bn Evercare Health Fund originally raised by Abraaj before TPG's takeover in 2019. Colella talks strategic priorities including 'turning Evercare from a fund into a real company', recent management departures, the platform today and why his own lack of emerging market healthcare service experience doesn't matter for this job.

Interview: Sofia Palmquist, CEO, Aleris

Pan-Nordic healthcare group Aleris lost its previous owner Investor AB nearly 1bn SEK (€90m) in its last nine months of ownership before PE group Triton acquired it in late 2019. New CEO Sofia Palmquist, pinched from competitor Capio, has been tasked with the turnaround and digitalisation of the company and gives HBI her first public interview since taking the job. 

Interview: Sanjeev Kanoria, Advinia Healthcare

HBI talks to Sanjeev Kanoria, founder and chairman of UK-based care home specialist Advinia Healthcare, about how COVID has affected his business, funding support, and the affect of Brexit on issues like recruitment.

Interview: Justin Ash, CEO, Spire Healthcare

COVID-19 transformed how private hospitals in the UK operate perhaps more than anywhere else, with groups like Spire becoming majority-funded by the NHS for the first time ever. But where does that leave its private business going forward and what has the experience been like? CEO Justin Ash discusses this as well as the lessons learned from recent investigations into transgressions at Spire hospitals.

Interview: Stuart Quin, CEO, Medica Group

What is the outlook for the UK teleradiology sector, with the largest player Medica's elective volumes still less than half of pre-COVID levels? We talk to CEO Stuart Quin about the group's recent H1 results and its strategy around specialist reporting, AI solutions, diversification and internationalisation, the latter of which has shifted since we last spoke.

Find Us